why choose us

Clinical Trials Search

Showing 7,870 of 132,656 result(s)
iTBS to Enhance Social Cognition in People With Psychosis

Status: Completed

Condition: Schizophrenia

Interventions:

The present study is a double-blind, randomized clinical trial that will examine if iTBS applied to DMPFC improves social cognitive performance com

Date: 2023-10-04

Preventing Injured Knees From osteoArthritis: Severity Outcomes

Status: NOT_YET_RECRUITING

Condition: Osteoarthritis, Knee

Interventions: Metformin is an oral anti-hyperglycemic agent widely used as first-line treatment for type II diabetes to improve glycemic control.
It is the fou

Date: 2023-10-04

A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis

Status: Completed

Condition: Rheumatoid Arthritis

Interventions: Tablet

Date: 2023-10-04

Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients

Status: Completed

Condition: Bariatric Surgery Candidate

Interventions: Patients will randomly be treated with either liposomal bupivacaine (study drug) after undergoing bariatric surgery.

Date: 2023-10-04

A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

Status: Completed

Condition: Psoriasis

Interventions: Tablet

Date: 2023-10-04

Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

Status: NOT_YET_RECRUITING

Condition: Atrial Fibrillation

Interventions: Acute ischemic stroke is a major cause of morbidity and mortality in non-valvular Atrial Fibrillation (AF).
Oral Anticoagulation (OAC) with Warfa

Date: 2023-10-04

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

Status: Completed

Condition: Unresectable Pleural Mesothelioma

Interventions: MEDI5752: Administered as IV infusion

Date: 2023-10-04

Emgality for Migraine in Breastmilk

Status: Completed

Condition: Migraine

Interventions: Receiving either 120mg or 300mg injections.

Date: 2023-10-04

Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan;Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

Status: Completed

Condition: Chronic Kidney Disease With High Proteinuria

Interventions: Participants will receive zibotentan;dapagliflozin in fixed-dose combination as per the arms they are randomized to

Date: 2023-10-04